Rapid Micro Biosystems RPID Cash, Cash Equivalents, and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by Rapid Micro Biosystems in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.
The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapid Micro Biosystems's cash, cash equivalents, and marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapid Micro Biosystems's cash, cash equivalents, and marketable securities?
- Rapid Micro Biosystems (RPID) reported cash, cash equivalents, and marketable securities of $9.13M in Q1 2026.
- How has Rapid Micro Biosystems's cash, cash equivalents, and marketable securities changed year-over-year?
- Rapid Micro Biosystems's cash, cash equivalents, and marketable securities decreased by 59.9% year-over-year, from $22.76M to $9.13M.
- What does cash, cash equivalents, and marketable securities mean?
- This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.